John H Weiland - Net Worth and Insider Trading

John H Weiland Net Worth

The estimated net worth of John H Weiland is at least $603,438 dollars as of 2024-11-08. John H Weiland is the Director of Celgene Corp and owns about 5,575 shares of Celgene Corp (CELG) stock worth over $603,438. Details can be seen in John H Weiland's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John H Weiland has not made any transactions after 2018-08-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of John H Weiland

To

John H Weiland Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John H Weiland owns 2 companies in total, including Cardinal Health Inc (CAH) , and West Pharmaceutical Services Inc (WST) .

Click here to see the complete history of John H Weiland’s form 4 insider trades.

Insider Ownership Summary of John H Weiland

Ticker Comapny Transaction Date Type of Owner
CAH Cardinal Health Inc 2019-09-01 director
WST West Pharmaceutical Services Inc 2007-05-01 director

John H Weiland Latest Holdings Summary

John H Weiland currently owns a total of 1 stock. John H Weiland owns 5,575 shares of Celgene Corp (CELG) as of August 7, 2018, with a value of $603,438.

Latest Holdings of John H Weiland

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CELG Celgene Corp 2018-08-07 5,575 108.24 603,438

Holding Weightings of John H Weiland


John H Weiland Form 4 Trading Tracker

According to the SEC Form 4 filings, John H Weiland has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the acquisition of 5,575 shares on August 7, 2018, which cost John H Weiland around $500,245.

Insider Trading History of John H Weiland

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John H Weiland Trading Performance

GuruFocus tracks the stock performance after each of John H Weiland's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John H Weiland is -16.44%. GuruFocus also compares John H Weiland's trading performance to market benchmark return within the same time period. The performance of stocks bought by John H Weiland within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John H Weiland's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John H Weiland

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.17 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -0.29 LIMIT LIMIT LIMIT LIMIT LIMIT

John H Weiland Ownership Network

Ownership Network List of John H Weiland

No Data

Ownership Network Relation of John H Weiland

Insider Network Chart

John H Weiland Owned Company Details

What does Cardinal Health Inc do?

Who are the key executives at Cardinal Health Inc?

John H Weiland is the director of Cardinal Health Inc. Other key executives at Cardinal Health Inc include Chief Legal/Compliance Officer Jessica L Mayer , Chief Financial Officer Jason M. Hollar , and Chief Financial Officer Aaron E Alt .

Cardinal Health Inc (CAH) Insider Trades Summary

Over the past 18 months, John H Weiland made no insider transaction in Cardinal Health Inc (CAH). Other recent insider transactions involving Cardinal Health Inc (CAH) include a net sale of 75,282 shares made by Jessica L Mayer , a net sale of 84,498 shares made by Stephen M Mason , and a net sale of 64,265 shares made by Ola M Snow .

In summary, during the past 3 months, insiders sold 198,902 shares of Cardinal Health Inc (CAH) in total and bought 0 shares, with a net sale of 198,902 shares. During the past 18 months, 369,588 shares of Cardinal Health Inc (CAH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 369,588 shares.

Cardinal Health Inc (CAH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cardinal Health Inc Insider Transactions

No Available Data

John H Weiland Mailing Address

Above is the net worth, insider trading, and ownership report for John H Weiland. You might contact John H Weiland via mailing address: C/o C.r Bard Inc, 730 Central Ave, Murray Hill Nj 07974.